Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
INDUSTRY
×
Urologic Neoplasms
×
pembrolizumab
×
Clear all
Filters
3
NCT03288545
2026-03-24
EV-103
Astellas Pharma Inc
Phase 1/2
Terminated
348 enrolled
2 FDA
NCT05614739
2026-03-23
FORAGER-1
Eli Lilly and Company
Phase 1
Recruiting
535 enrolled
NCT02783300
2025-03-10
Meteor 1
GlaxoSmithKline
Phase 1
Completed
297 enrolled
76 charts